Castleman's disease: A condition with protean manifestations

Onkologie

Volumn 34, Issue 8-9, 2011, Pages 412-414

  Roca, Bernardino ^a  

^a UNIVERSITAT JAUME I   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BORTEZOMIB; FLUORODEOXYGLUCOSE; GLUCOCORTICOID; HEPCIDIN; INTERLEUKIN 6; RETINOIC ACID; RITUXIMAB; SILTUXIMAB; SURAMIN; THALIDOMIDE; TOCILIZUMAB;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; CALCIFICATION; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DISEASE SEVERITY; EDITORIAL; HUMAN; HUMAN HERPESVIRUS 8; IRON DEFICIENCY ANEMIA; LYMPH NODE; LYMPHADENOPATHY; MULTIPLE CANCER; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; RARE DISEASE;

ANEMIA, HYPOCHROMIC; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HUMANS;

EID: 80053245477     PISSN: 0378584X     EISSN: 14230240     Source Type: Journal    
DOI: 10.1159/000331504     Document Type: Editorial

References (26)

1. Castleman B, Towne VW: Case records of the Massachusetts General Hospital: Case No. 402 31. N Engl J Med 1954;250:1001-1005.
2. Roca B: ' Disease. A Review. AIDS Rev 2009;11:3-7.
3. Stebbing J, Pantanowitz L, Dayyani F, Sullivan RJ, Bower M, Dezube BJ: HIV-associated multicentric ' disease. Am J Hematol 2008;83:498-503.
4. Dham A, Peterson BA: Castleman disease. Curr Opin Hematol 2007;14:354-359. (Pubitemid 46842810)
5. van Rhee F, Stone K, Szmania S, Barlogie B, Singh Z: Castleman disease in the 21st century: An update on diagnosis, assessment, and therapy. Clin Adv Hematol Oncol 2010;8:486-498.
6. Kojima M, Motoori T, Asano S, Nakamura S: Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients. Pathol Res Pract 2007; 203:423-431. (Pubitemid 46852314)
7. Mylona EE, Baraboutis IG, Lekakis LJ, Georgiou O, Papastamopoulos V, Skoutelis A: Multicentric ' disease in HIV infection: A systematic review of the literature. AIDS Rev 2008;10:25-35. (Pubitemid 351524049)
8. Naresh KN, Rice AJ, Bower M: Lymph nodes involved by multicentric Castleman disease among HIV-positive individuals are often involved by Kaposi sarcoma. Am J Surg Pathol 2008;32:1006-1012.
9. Dispenzieri A: POEMS syndrome. Blood Rev 2007;21:285-299. (Pubitemid 47498680)
10. Newlon JL, Couch M, Brennan J: ' disease: Three case reports and a review of the literature. Ear Nose Throat J 2007;86:414-418. (Pubitemid 351954485)
11. Coca S, Salas I, Martínez R, Saez MA, Vaquero J: Meningeal ' disease with multifocal involvement: A case report and review of literature. J Neurooncol 2008;88:37-41.
12. Kojima M, Nakamura N, Tsukamoto N, Otuski Y, Shimizu K, Itoh H, Kobayashi S, Kobayashi H, Murase T, Masawa N, Kashimura M, Nakamura S: Clinical implications of idiopathic multicentric Castleman disease among Japanese: A report of 28 cases. Int J Surg Pathol 2008;16:391-398.
13. Jongsma TE, Verburg RJ, Geelhoed-Duijvestijn PH: ' disease: A rare lymphoproliferative disorder. Eur J Intern Med 2007;18:87-89.
14. Enomoto K, Nakamichi I, Hamada K, Inoue A, Higuchi I, Sekimoto M, Mizuki M, Hoshida Y, Kubo T, Aozasa K, Hatazawa J: Unicentric and multicentric ' disease. Br J Radiol 2007;80:e24-e26.
15. Roca B, Torres V: ' disease presenting as fever of unknown origin: Diagnostic value of fluorodeoxyglucose-positron emission tomography/ computed tomography. Am J Med Sci 2009; 337:295-296.
16. Hoffmann C, Schmid H, Müller M, Teutsch C, van Lunzen J, Esser S, Wolf T, Wyen C, Sabranski M, Horst HA, Reuter S, Vogel M, Jäeger H, Bogner J, Arasteh K: Improved outcome with rituximab in patients with HIV-associated multicentric Castleman disease. Blood 2011;doi:10.1182/blood-2011- 02-333633.
17. Hess G, Wagner V, Kreft A, Heussel CP, Huber C: Effects of bortezomib on pro-inflammatory cytokine levels and transfusion dependency in a patient with multicentric Castleman disease. Br J Haematol 2006;134:544-545. (Pubitemid 44141721)
18. van Rhee F, Fayad L, Voorhees P, Furman R, Lonial S, Borghaei H, Sokol L, Crawford J, Cornfeld M, Qi M, Qin X, Herring J, Casper C, Kurzrock R: Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for ' disease. J Clin Oncol 2010;28:3701-3708.
19. Matsuyama M, Suzuki T, Tsuboi H, Ito S, Mamura M, Goto D, Matsumoto I, Tsutsumi A, Sumida T: Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric ' disease. Intern Med 2007;46:771-774. (Pubitemid 46902277)
20. El-Osta HE, Kurzrock R: ' disease: From basic mechanisms to molecular therapeutics. Oncologist 2011;16:497-511.
21. Yuzuriha A, Saitoh T, Koiso H, Mitsui T, Uchiumi H, Yokohama A, Handa H, Kojima M, Tsukamoto N, Karaswa M, Murakami H, Nojima Y: Successful treatment of autoimmune hemolytic anemia associated with multicentric Castleman disease by antiinterleukin- 6 receptor antibody (tocilizumab) therapy. Acta Haematol 2011;126:147-150.
22. Dispenzieri A: POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol 2011;86:591-601.
23. Weng CH, Chen JB, Wang J, Wu CC, Yu Y, Lin TH: Surgically curable non-iron deficiency microcytic anemia: ' disease. Onkologie 2011;34: DOI: 10.1159/000331283.
24. Bejjani J, Lemieux B, Gariepy G, Younan R: Complete anemia reversal after surgical excision of mesenteric hyaline-vascular unicentric Castleman disease. Can J Surg 2009;52:E197-E198.
25. Cherayil BJ, Ellenbogen S, Shanmugam NN: Iron and intestinal immunity. Curr Opin Gastroenterol 2011 Jul 22. Epub ahead of print]
26. Picotte M, Campbell CG, Thorland WG: Day-today variation in plasma interleukin-6 concentrations in older adults. Cytokine 2009;47:162-165.